Page last updated: 2024-08-24

topotecan and Adrenal Cancer

topotecan has been researched along with Adrenal Cancer in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scorsone, K; Woodfield, SE; Zage, PE; Zhang, L1
Deméocq, F; Halle, P; Isfan, F; Kanold, J; Kelly, A; Lang, P; Marabelle, A; Merlin, E; Paillard, C; Rochette, E; Tchirkov, A1
Castellano, A; De Ioris, MA; De Laurentis, C; Dominici, C; Donfrancesco, A; Garganese, MC; Ilari, I; Jenkner, A; Milano, GM1
Cheshire, PJ; Houghton, JA; Houghton, PJ; Luo, X; Poquette, C; Richmond, LB; Santana, VM; Stewart, CF; Thompson, J; Zamboni, WC1

Other Studies

4 other study(ies) available for topotecan and Adrenal Cancer

ArticleYear
Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition.
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

    Topics: Administration, Oral; Adrenal Gland Neoplasms; Anilides; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Immunocompromised Host; Inhibitory Concentration 50; Isotretinoin; MAP Kinase Signaling System; Mice; Neoplasm Proteins; Neuroblastoma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Pyridines; Temozolomide; Topotecan; Xenograft Model Antitumor Assays

2015
NK cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT.
    Pediatric blood & cancer, 2012, Volume: 59, Issue:4

    Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Bone Marrow Neoplasms; Bone Neoplasms; Child; Combined Modality Therapy; Dacarbazine; Doublecortin Domain Proteins; Haplotypes; Hematopoietic Stem Cell Transplantation; Homeodomain Proteins; Humans; Immunotherapy; Interleukin-2; Killer Cells, Natural; Male; Microtubule-Associated Proteins; Neoplasm, Residual; Neuroblastoma; Neuropeptides; Remission Induction; Temozolomide; Topotecan; Transcription Factors; Transplantation, Homologous; Tyrosine 3-Monooxygenase

2012
Prolonged response to oral gefitinib, cyclophosphamide, and topotecan in heavily pretreated relapsed stage 4 neuroblastoma: a case report.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:11

    Topics: Administration, Oral; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Female; Gefitinib; Humans; Neuroblastoma; Quinazolines; Radionuclide Imaging; Recurrence; Topotecan; Treatment Outcome

2007
Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts.
    Journal of the National Cancer Institute, 1998, Apr-01, Volume: 90, Issue:7

    Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Bone Marrow Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Mice; Mice, Inbred CBA; Neuroblastoma; Retroperitoneal Space; Rhabdomyosarcoma; Topoisomerase I Inhibitors; Topotecan; Transplantation, Heterologous

1998